Sales & Marketing AI and pharma launch - Within3’s Jason Smith Jason Smith, CTO of AI and analytics at Within3, discusses data-fuelled agile launches and smarter decision-making.
R&D Bioconvergence & future human health, with Shai Melcer Shai Melcer discusses bioconvergence, a multidisciplinary research and development approach that merges technologies.
Digital Sponsored AI-enabled pharmacovigilance, with Updesh Dosanjh Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.
Oncology Getting predictive technologies to patients, with Concr Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.
Market Access Sponsored Europe for life sciences and for patients, with BeOne Medici... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.
Digital Sponsored Ethical AI & trust-driven innovation: UCB’s Erik Janssen How can pharma lead the way in ethical AI and trust-driven innovation?
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.